Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Paul

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Plos One|January 22, 2021
Realist evaluation to improve health systems responsiveness to neglected health needs of vulnerable groups in Ghana and Vietnam: Study protocolTolib Mirzoev, Ana Manzano, Bui Thi Thu Ha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2021
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)Evanthia T Roussos Torres, Christine Rafie, Chenguang Wang, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 27, 2020
Addressing Unintentional Exclusion of Vulnerable and Mobile Households in Traditional Surveys in Kathmandu, Dhaka, and Hanoi: a Mixed-Methods Feasibility StudyDana R Thomson, Radheshyam Bhattarai, Sudeepa Khanal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion CohortLaura Q M Chow, Robert Haddad, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumorsGeoffrey I Shapiro, Raoul Tibes, Michael S Gordon, et al.
BMJ Open|November 28, 2018
Improving household surveys and use of data to address health inequities in three Asian cities: protocol for the Surveys for Urban Equity (SUE) mixed methods and feasibility studyHelen Elsey, Ak Narayan Poudel, Tim Ensor, et al.
Nature Communications|July 7, 2023
Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographsAyis Pyrros, Stephen M Borstelmann, Ramana Mantravadi, et al.
Heart (British Cardiac Society)|October 13, 2020
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillationJonathan P Piccini, Derick M Todd, Tyler Massaro, et al.
The Lancet. Oncology|June 9, 2016
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trialScott J Antonia, José A López-Martin, Johanna Bendell, et al.
Nature Communications|June 6, 2024
Author Correction: Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographsAyis Pyrros, Stephen M Borstelmann, Ramana Mantravadi, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Plos One|January 22, 2021
Realist evaluation to improve health systems responsiveness to neglected health needs of vulnerable groups in Ghana and Vietnam: Study protocolTolib Mirzoev, Ana Manzano, Bui Thi Thu Ha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2021
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)Evanthia T Roussos Torres, Christine Rafie, Chenguang Wang, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 27, 2020
Addressing Unintentional Exclusion of Vulnerable and Mobile Households in Traditional Surveys in Kathmandu, Dhaka, and Hanoi: a Mixed-Methods Feasibility StudyDana R Thomson, Radheshyam Bhattarai, Sudeepa Khanal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion CohortLaura Q M Chow, Robert Haddad, Shilpa Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumorsGeoffrey I Shapiro, Raoul Tibes, Michael S Gordon, et al.
BMJ Open|November 28, 2018
Improving household surveys and use of data to address health inequities in three Asian cities: protocol for the Surveys for Urban Equity (SUE) mixed methods and feasibility studyHelen Elsey, Ak Narayan Poudel, Tim Ensor, et al.
Nature Communications|July 7, 2023
Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographsAyis Pyrros, Stephen M Borstelmann, Ramana Mantravadi, et al.
Heart (British Cardiac Society)|October 13, 2020
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillationJonathan P Piccini, Derick M Todd, Tyler Massaro, et al.
The Lancet. Oncology|June 9, 2016
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trialScott J Antonia, José A López-Martin, Johanna Bendell, et al.
Nature Communications|June 6, 2024
Author Correction: Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographsAyis Pyrros, Stephen M Borstelmann, Ramana Mantravadi, et al.
Pageof 18